Bioequivalence of Fresenius Kabi USA, LLC Glucagon for SC Injection Compared to Glucagon for Injection (Bedford Laboratories)
Phase 1
Completed
- Conditions
- Hypoglycemia
- Interventions
- First Posted Date
- 2014-03-13
- Last Posted Date
- 2014-03-13
- Lead Sponsor
- Fresenius Kabi USA, LLC
- Target Recruit Count
- 32
- Registration Number
- NCT02086227
- Locations
- 🇺🇸
West Houston Clinical Research Services, 2026 Wirt Road, Houston, Texas, United States
© Copyright 2025. All Rights Reserved by MedPath